We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Nuformix Plc | LSE:NFX | London | Ordinary Share | GB00BYW79Y38 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.01 | -5.41% | 0.175 | 0.17 | 0.18 | - | 1,097,760 | 16:35:25 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -859k | -0.0012 | -1.50 | 1.34M |
Date | Subject | Author | Discuss |
---|---|---|---|
27/2/2024 20:10 | He Basically confirmed AZN are in the mix Risk / reward here is pretty phenomenal for the latter Would be nice for another He1 result ! | amaretto1 | |
27/2/2024 19:21 | Relax boys. It's Dan "All in the bag "' | vlad the impaler | |
27/2/2024 19:14 | Ps.Companies are reluctant to sign deals due to the money invested and previous failures in IPF.Work needed to persuade them to part with their money.NFX novel pathway and inhaled therapy may sway them. | peverill | |
27/2/2024 19:09 | Well nothing new,nothing imminent deal wise,looks like they need orphan drug status to progress anything,which is a few month away,Talking to AZ,hinted at but kind of confirmed it,nudge nudge wink wink style.The rest of it was buttering up so everyone will vote the resolutions through for AGM.Patents news soon,but we knew that.And they need money or an investment,which we know. | peverill | |
26/2/2024 18:57 | Working hard on that deal then? | for fx sake | |
26/2/2024 18:03 | Im sure an RNS pre telegram better anyway | institutional investments | |
26/2/2024 18:02 | Don't be harsh on Dan Gift coming | institutional investments | |
26/2/2024 18:01 | Todays visit from Dan on Telegram was cancelled,He had an accident in France and was hospitalised for a few days,flew back today. | peverill | |
26/2/2024 10:34 | Personally think it's a bad idea anyway. | peverill | |
26/2/2024 09:01 | Says it all really.What about those shareholders who don't use Telegram? I guess they don't matter. | for fx sake | |
26/2/2024 08:46 | He is supposed to be on the telegram bb today at 4 o'clock answering a few questions.Wouldnt think he can say too much but just letting people he is still about. | peverill | |
25/2/2024 22:56 | Has Dan retired or joined a convent to meditate his next move. | jotoha2 | |
12/2/2024 12:08 | Whatever works then 😂 | institutional investments | |
09/2/2024 07:41 | All smoke and mirrors if you ask me. | the imperialist | |
09/2/2024 00:22 | Problem here is that Dan is not very good at painting a good picture of the so called link with a major partner , small investors have kept this company alive , so lets have some returns please Mr Dan . | jotoha2 | |
08/2/2024 12:40 | By 3rd day in March latest, I'm sure we know all | institutional investments | |
08/2/2024 12:36 | Give it a few more weeks,nothing too lose now given the price. | peverill | |
08/2/2024 11:29 | This is a basket case II. Time to move on. | the imperialist | |
05/2/2024 22:22 | Although I suppose markets don't really matter that much to a cap like this . But still prefer this week, not month lol | institutional investments | |
05/2/2024 22:21 | This month anyway ..but this week better given state of markets out there . The look of them anyway | institutional investments | |
05/2/2024 22:20 | Dint mind the fall back yet. It's above right price still. But news expected, and really would like it to be this very week | institutional investments | |
05/2/2024 22:19 | Little disapointing that it fell back from .4 lets hope Dan is achieving his intended negotiations and the share price will reflect all the time he has had to come good here. | jotoha2 | |
05/2/2024 21:46 | Needs to get going this week. News required | institutional investments |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions